Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) Insider Sells $145,230.41 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) insider Jamie Samath sold 269 shares of the business’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Jamie Samath also recently made the following trade(s):

• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $537.80 on Friday. Intuitive Surgical, Inc. has a 52-week low of $291.39 and a 52-week high of $544.38. The firm has a 50 day moving average price of $496.95 and a two-hundred day moving average price of $455.65. The stock has a market cap of $191.55 billion, a P/E ratio of 86.46, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC boosted its stake in shares of Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares during the last quarter. Capital Research Global Investors bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at $374,390,000. FMR LLC boosted its stake in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after purchasing an additional 493,126 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. Raymond James upped their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Mizuho upped their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.